| ||Audit Committee||Compensation Committee||Nominating/Corporate Governance Committee|
|Louis C. Bock |
|Louis C. Bock|
Louis C. Bock has served as a member of our board of directors since August 2006. Mr. Bock was previously Managing Director of Scale Venture Partners, a venture capital firm. Mr. Bock joined Scale Venture Partners in September 1997 from Gilead Sciences, Inc., a biopharmaceutical company, where he held positions in research, project management, business development and sales from September 1989 to September 1997. Prior to Gilead, he was a research associate at Genentech, Inc. from November 1987 t...
|James B. Breitmeyer, M.D., Ph.D. |
|James B. Breitmeyer, M.D., Ph.D.|
Dr. Breitmeyer has served as a member of our board of directors since March 2014. He currently serves as President of Bavarian Nordic, Inc., a late-stage biotechnology company focused on developing and producing novel immunotherapy candidates for the treatment of life-threatening diseases. He is also Executive Vice President of Bavarian A/S, a multinational corporation headquartered in Denmark, that is highly specialized in the research, development and manufacturing of vaccines and immunotherap...
|Stephen J. Farr, Ph.D. |
|Stephen J. Farr, Ph.D.|
Stephen J. Farr, Ph.D. is one of our co-founders and has served as our President and as a member of our board of directors since our inception in May 2006. From May 2006 to August 2006, Dr. Farr also served as our Chief Executive Officer and since August 2006, Dr. Farr has served as our Chief Operating Officer. From 1995 to August 2006, Dr. Farr held positions of increasing responsibility within pharmaceutical sciences and research and development at Aradigm Corporation, and he served most recen...
| || || |
|Cam L. Garner |
|Cam L. Garner|
Cam L. Garner is one of our co-founders and has served as chairman of our board of directors since August 2006. Mr. Garner co-founded specialty pharmaceutical companies Cadence Pharmaceuticals, Inc., Somaxon Pharmaceuticals, Inc., Evoke Pharma, Inc., Elevation Pharmaceuticals, Inc., DJ Pharma, Xcel Pharmaceuticals, Inc. and Meritage Pharma, Inc. He has served as Chairman of Cadence, Evoke, Elevation and Meritage since May 2004, January 2007, December 2007 and February 2008, respectively. Xcel wa...
|Roger L. Hawley |
|Roger L. Hawley|
Roger L. Hawley is one of our co-founders and has served as our Chief Executive Officer and as a member of our board of directors since August 2006. From January 2006 to August 2006, Mr. Hawley served as a consultant to CG Pharma, Inc. From August 2003 to January 2006 he served as Executive Vice President, Commercial and Technical Operations for InterMune, Inc., a biopharmaceutical company focused on therapies in hepatology and pulmonology. From October 2002 to July 2003, Mr. Hawley was the Chie...
| || || |
|Erle T. Mast
|Erle T. Mast|
Erle T. Mast has served as a member of our board of directors since May 2008. Mr Mast has served as Executive Vice President, Chief Financial Officer with Clovis Oncology since May 2009. From July 2002 to May 2008, Mr. Mast served as Executive Vice President and Chief Financial Officer of Pharmion Corporation, until its acquisition by Celgene Corporation. From 2000 to 2002, after Elan Pharma International Ltd. acquired Dura Pharmaceuticals, Inc., Mr. Mast served as Chief Financial Officer for th...
|Renee Tannenbaum |
Renee Tannenbaum has served as a member of our board since February 2015. She currently serves as the Head of Global Customer Excellence of AbbVibe, Inc., where she is responsible for building commercial capabilities. Dr. Tannenbaum was previously President of Myrtle Potter & Company, LLC, a global life sciences consulting and advisory firm. From 2009 to 2011, she served as Executive Vice President and Chief Commercial Officer at Elan Pharmaceutics, Inc., where she was responsible for revenue ge...
| || ||
|Mark Wiggins |
Mark Wiggins has served as a member of our board of directors since May 2011. Mr. Wiggins currently serves as the Chief Business Officer of Mpex Pharmaceuticals overseeing strategic business operations of the company. Prior to Mpex, Mr. Wiggins served as Executive Vice President, Corporate and Business Development of Biogen Idec, Inc. In this position, he was responsible for worldwide partnering, licensing and corporate acquisitions. Prior to Biogen’s merger with Idec Pharmaceuticals in 2003...